BRCA1 and breast cancer: BRCA1/2 pathogenic variant heterozygotes in this study were selected based on having a first breast cancer; these women will have on average a higher PRS, but also higher frequencies of other genetic and nongenetic risk factors than women who do not develop breast cancer at all.